Cargando…
NVP-BKM120 inhibits colon cancer growth via FoxO3a-dependent PUMA induction
NVP-BKM120, a potent and highly selective PI3K inhibitor, is currently being investigated in phase I/II clinical trials. The mechanisms of action of NVP-BKM120 in colon cancer cells are unclear. In the present study, we investigated how NVP-BKM120 suppresses colon cancer cells growth and potentiates...
Autores principales: | Yang, Shida, Li, Xin, Guan, Wenchang, Qian, Mingqin, Yao, Zhicheng, Yin, Xiaoxue, Zhao, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669949/ https://www.ncbi.nlm.nih.gov/pubmed/29137323 http://dx.doi.org/10.18632/oncotarget.20943 |
Ejemplares similares
-
Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth
por: Padthaisong, Sureerat, et al.
Publicado: (2018) -
Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer
por: Yan, Ji, et al.
Publicado: (2020) -
The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia
por: Allegretti, Matteo, et al.
Publicado: (2015) -
MEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells
por: Lin, Lin, et al.
Publicado: (2018) -
Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells
por: Hu, Y, et al.
Publicado: (2015)